頭頸部癌術後患者のQOLに関わる因子の経時的変化について　―術前、術後1か月、術後3か月の比較― by 田下 雄一
Supportive Care in Cancer
 
Longitudinal Change of Quality of Life from Pre- to 3 Months after Surgical Treatment
in Head and Neck Cancer Patients
--Manuscript Draft--
 
Manuscript Number:
Full Title: Longitudinal Change of Quality of Life from Pre- to 3 Months after Surgical Treatment
in Head and Neck Cancer Patients
Article Type: Original Article
Corresponding Author: Yoshiaki Ihara, Ph.D
Showa Univeristy
Ohta-ku, Tokyo JAPAN
Corresponding Author Secondary
Information:
Corresponding Author's Institution: Showa Univeristy
Corresponding Author's Secondary
Institution:
First Author: Yuichi Tashimo, DDS.
First Author Secondary Information:
Order of Authors: Yuichi Tashimo, DDS.
Yoshiaki Ihara, DDS., Ph.D.
Ken Yuasa, DDS., Ph.D.
Shinji Nozue, DDS., Ph.D.
Yoshiro Saito, DDS., Ph.D.
Hideyuki Katsuta, DDS., Ph.D.
Toshikazu Shimane, MD., Ph.D.
Koji Takahashi, DDS., Ph.D.
Order of Authors Secondary Information:
Funding Information:
Abstract: Purpose: Head and neck cancer (HNC) patients experience various posttreatment side
effects that decrease quality of life (QOL). However, longitudinal changes of QOL in
HNC patients remains unclear. This study aimed to investigate the longitudinal change
of QOL in HNC patients had surgery.
Methods: 45 HNC patients (23 men) who were scheduled for surgical treatment were
enrolled in this study. Primary tumor sites were 22 tongue, 5 maxilla, 4 mandible, 3
pharynx and others. Weight, body mass index (BMI), whole body soft lean mass
(SLM), and skeletal muscle mass (SMM) were evaluated as muscle mass-related
measurements. Lip closure force (LC) and tongue pressure (TP) were evaluated as
oral function measurements. Feeding function was evaluated using the Functional Oral
Intake Scale (FOIS). QOL was assessed using the European Organization for
Research and Treatment of Cancer QOL Questionnaire QLQ-C30 and H&N 35.
Measures were evaluated at pre-surgical treatment (PT), and 1 month (1M) and 3
months (3M) after surgery. The change of QOL parameters and relationships between
measurements were assessed.
Results: For QOL assessments, role functioning, fatigue, speech problems, trouble
with social eating, trouble with social contact, and opening mouth significantly
decreased from PT to 1M, but significantly increased from 1M to 3M. Weight, BMI,
SLM, SMM, LC, TP, and FOIS demonstrated significant relationships with QOL from
PT to 1M. Meanwhile, from 1M to 3M, weight, BMI, SLM, SMM, LC, and FOIS showed
significant relationships with QOL assessments.
Conclusions: Both oral function and muscle mass-related measurements significantly
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
affected QOL in HNC patients.
Suggested Reviewers: Michael E Groher
University of Redlands
Michael_Groher@redlands.edu
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
1 
 
Title: Longitudinal Change of Quality of Life from Pre- to 3 Months after Surgical Treatment in Head and 
Neck Cancer Patients 
Yuichi Tashimo1, Yoshiaki Ihara1, Ken Yuasa1, Shinji Nozue1, Yoshiro Saito2, Hideyuki Katsuta2, Toshikazu 
Shimane2, Koji Takahashi1 
1Division of Oral Rehabilitation Medicine, Department of Special Needs Dentistry, Showa University 
School of Dentistry, Tokyo, Japan 
2Head and Neck Oncology Center, Showa University Hospital, Tokyo, Japan 
ORCID of the authors: 0000-0001-7961-2445 (Yuichi Tashimo) 
Corresponding author:  
Yoshiaki Ihara, PhD 
Division of Oral Rehabilitation Medicine, Department of Special Needs Dentistry 
Showa University School of Dentistry, Tokyo, Japan 
Phone number: +81-33787-1151 
Manuscript Click here to access/download;Manuscript;Final#1.docx
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
 
e-mail address: ikkun@dent.showa-u.ac.jp  
ORCID: 0000-0002-4324-2670 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
 
Abstract 
Purpose: Head and neck cancer (HNC) patients experience various posttreatment side effects that 
decrease quality of life (QOL). However, longitudinal changes of QOL in HNC patients remains unclear. 
This study aimed to investigate the longitudinal change of QOL in HNC patients had surgery. 
Methods: 45 HNC patients (23 men) who were scheduled for surgical treatment were enrolled in this 
study. Primary tumor sites were 22 tongue, 5 maxilla, 4 mandible, 3 pharynx and others. Weight, body 
mass index (BMI), whole body soft lean mass (SLM), and skeletal muscle mass (SMM) were evaluated 
as muscle mass-related measurements. Lip closure force (LC) and tongue pressure (TP) were evaluated as 
oral function measurements. Feeding function was evaluated using the Functional Oral Intake Scale 
(FOIS). QOL was assessed using the European Organization for Research and Treatment of Cancer QOL 
Questionnaire QLQ-C30 and H&N 35. Measures were evaluated at pre-surgical treatment (PT), and 1 
month (1M) and 3 months (3M) after surgery. The change of QOL parameters and relationships between 
measurements were assessed. 
Results: For QOL assessments, role functioning, fatigue, speech problems, trouble with social eating, 
trouble with social contact, and opening mouth significantly decreased from PT to 1M, but significantly 
increased from 1M to 3M. Weight, BMI, SLM, SMM, LC, TP, and FOIS demonstrated significant 
relationships with QOL from PT to 1M. Meanwhile, from 1M to 3M, weight, BMI, SLM, SMM, LC, and 
FOIS showed significant relationships with QOL assessments. 
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Conclusions: Both oral function and muscle mass-related measurements significantly affected QOL in 
HNC patients. 
Key words: Quality of life, Muscle mass, Oral function, Feeding function, Head and neck cancer   
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Introduction 
Currently, both the prevalence and survival rates of head and neck cancer (HNC) are increasing 
[1] owing to advances in medical technology [2, 3]. HNC markedly affects not only oral function, but also 
the cosmetic and psychological aspects [4, 5]. The acute side effects of treatment may persist beyond 
treatment, while additional chronic effects may develop after at least 90 days after treatment discontinuation 
[6, 7]. Common oral morbidities resulting from HNC treatment include oral pain, oral dryness, and altered 
taste and smell perception. One of the most prevalent and debilitating side effects of HNC treatment is 
dysphagia (i.e., swallowing difficulty) [8] that may develop as both acute and chronic complication of HNC 
treatment [9, 10]. Dysphagia has been reported in over 76% of HNC patients treated with concurrent 
chemotherapy (CRT). It decreases the patient’s quality of life (QOL) following HNC treatment [11, 12]. 
QOL is considered to be an important factor in both treatment decision and outcome evaluation [12-15]. 
Particularly, QOL is necessary in multidirectional analysis and appropriate evaluation of treatment results. 
The result of HNC treatment should be evaluated according to both QOL and posttreatment 
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functional outcomes [16]. However, only few studies have conducted a multidirectional analysis that 
include QOL before and after HNC treatment. Further, majority of previous studies focused on HNC 
patients who received chemoradiation therapy [3,4,8-11] and thus the association between QOL and other 
functions in HNC patients who underwent surgery remains unclear.  
This study aimed to investigate the longitudinal change of QOL in HNC patients who 
underwent surgery by conducting a multidirectional analysis of pre- and posttreatment QOL.  
Materials and Methods 
Patients 
This study included HNC patients who were scheduled for surgical treatment at the Head and 
Neck Oncology Center, Showa University Hospital and were then referred to the Department of Special 
Needs Dentistry, Division of Oral Rehabilitation Medicine, Showa University Dental Hospital for 
rehabilitation. The exclusion criteria were (1) age < 20 years, (2) inability to follow instructions, (3) other 
malignant tumors, (4) severe systemic diseases that may influence the evaluation, and (5) incomplete 
measurement data.  
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Assessments  
All measurements were performed by dentists of the Department of Special Needs Dentistry, 
Division of Oral Rehabilitation Medicine, Showa University Dental Hospital. The primary tumor site, TNM 
Classification, method of surgical operation, and medical history were collected from the medical records. 
The patient’s weight, body mass index (BMI), whole body soft lean mass (SLM), and skeletal muscle mass 
(SMM) were evaluated as muscle mass-related measurements. Lip closure force (LC) and tongue pressure 
(TP) were evaluated as oral function measurements. Feeding function was evaluated using the Functional 
Oral Intake Scale (FOIS), while QOL was assessed using the European Organization for Research and 
Treatment of Cancer (EORTC) QOL Questionnaire QLQ-C30 and QLQ-H&N 35. 
Patients were examined at pre-surgical treatment (PT; 2 weeks to 2 days before surgery), a month after 
surgery (1M), and 3 months after surgery (3M).  
Muscle mass-related measurements 
SLM and SMM were measured using Inbody S20 (BioSpace, Seoul, Korea), which can evaluate 
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the patient’s SLM and SMM in supine position. The patients were placed in the supine position on the 
examination table, with four electrodes on the first and third fingers and four points on the left and right 
ankles, totaling to 8 contact-type electrodes [17]. The patient’s weight was measured at each time point. 
Changes in body weight and percentage of body weight from baseline (PT) to each time point were 
calculated. 
Oral function measurements  
LC was measured 5 times using a lip force measuring device (Lip de Cum model LDC-110R, 
Cosmo-Instruments Co, Ltd, Tokyo, Japan). The average score of the 5 measurements was then calculated 
as the LC score [18,19]. 
 TP was evaluated using the JMS tongue pressure measuring device (JMS Co. Ltd., Hiroshima, Japan). 
The balloon-shaped intraoral probe was placed behind the upper front teeth. Patients were instructed to 
push the probe with the maximum force between the hard palate and tongue, and changes in air pressure 
inside the probe was measured. The measurement was performed 10 times, and the average score was 
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calculated as the TP score [20]. 
Feeding function 
The FOIS was used as a measure of functional eating status [21]. The FOIS is a valid and reliable 
tool used to document functional eating abilities. A 7-point ordinal scale describes the functional oral intake 
of patients with dysphagia. 
QOL measurements  
QOL was assessed using the Japanese version of EORTC QLQ-C30 version 3.0 and QLQ-
H&N35 questionnaires. The scores were calculated according to the EORTC scoring manual [22,23]. 
Statistical analysis 
Univariate analyses of potential associations were conducted using t-tests for the comparison of 
all measurements at each time point. Spearman’s rank correlation coefficient was used to evaluate the 
relationships among QOL measurements that significantly decreased after HNC treatment and other 
measurements from PT to 1M and 1M to 3M. Statistical analyses were performed using IBM SPSS version 
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25 (IBM, New York, USA). All p values were two-sided, and p < 0.05 was considered significant. 
Results 
Patients 
A total of 45 patients (23 men and 22 women) were included in the study. The mean patient age 
was 66.51 years (SD: 12.5 years). The primary tumor site was the tongue, maxilla, mandible, pharynx, 
and others in 22, 5, 4, 3, and 11 patients, respectively. The patients’ characteristics are detailed in Table 1.  
Muscle mass-related measurements 
Weight: At PT, the average weight was 60.27 kg (SD = 13.02 kg). A significant reduction was 
observed at 1M (mean: 58.32 kg, SD = 11.82 kg; t = 5.41, p < .001), while no significant increase was 
noted from 1M to 3M (mean: 58.10 kg, SD = 12.23 kg; t = -0.59, p = .560). In addition, the average 
weight was significantly reduced from PT to 3M (t = 3.86, p < .001; Fig. 1a). 
BMI: At PT, the average BMI was 23.02 kg/m2 (SD = 3.52 kg/m2). A significant reduction was 
observed at 1M (mean: 22.20 kg/m2, SD = 3.41 kg/m2; t=5.75, p < .001). However, the average BMI was 
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not significantly increased at 3M (mean: 22.40 kg/m2, SD = 3.40 kg/m2) than that at 1M (t = 0.29, p 
= .770). Furthermore, the average BMI at 3M was significantly reduced from that at PT (t = 3.95, p 
< .001; Fig. 1b). 
SLM: At PT, the average SLM was 38.32 kg (SD = 9.52 kg). A significant reduction was 
observed at 1M (mean: 38.00 kg, SD = 8.81 kg; t = 2.10, p = .040)). Meanwhile, no significant change in 
the average SLM was observed at 3M compared to that at 1M (mean: 38.00 kg, SD = 9.22 kg; t = 1.57, p 
= .125). Furthermore, the average SLM at 3M showed no significant changes (t = 1.30, p = .200) 
compared to that at PT (Fig. 1c). 
SMM: At PT, the average SMM was 22.10 kg (SD = 5.82 kg). A significant reduction was 
observed at 1M (mean: 21.72 kg, SD = 5.23 kg; t = 2.59, p = .010). Meanwhile, there was no significant 
reduction in the average SMM at 3M (mean: 21.79 kg, SD = 5.57 kg; t = -1.97, p = .056) compared to that 
at 1M. Furthermore, no significant change in the average SMM at 3M compared to that at PT was noted (t 
= 1.66, p = .100; Fig. 1d). 
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Oral function measurements 
LC: At PT, the average LC was 12.33 N (SD = 3.03 N). A significant reduction was observed at 
1M (mean: 10.80 N, SD = 3.19 N; t = 3.47, p = .001). Meanwhile, the average LC showed no significant 
change at 3M compared to that at 1M (mean: 11.79 N, SD = 3.27 N; t = -1.73, p = .092). Furthermore, the 
average LC at 3M showed no significant change compared to that at PT (t = 1.56, p = .127; Fig. 2a). 
TP: At PT, the average TP was 26.89 kPa (SD = 10.21 kPa). A significant reduction (was 
observed at 1M (mean: 22.30 kPa, SD = 11.43; t = 4.23, p < .001). At 3M, the average TP was 
significantly increased (mean: 25.47 kPa, SD = 12.23; t = -3.17, p = .003) compared to that at 1M. 
Meanwhile, the average TP at 3M showed no significant change compared to that at PT (t = 1.65, p 
= .107; Fig. 2b). 
Feeding function 
FOIS: At PT, the average FOIS was 6.73 (SD = 0.72). At 1M, the mean FOIS was significantly 
decreased (mean: 5.89; SD = 1.49; t = 4.07, p < .001). Meanwhile, the mean FOIS score at 3M was 
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significantly increased compared to that at 1M (mean: 6.36, SD = 1.49; t = -3.17, p = .003). Furthermore, 
the average FOIS at 3M was not significantly different from that at PT (t = 1.88, p = .068; Fig. 2c). 
QOL measurements 
For QOL measurements, no significant change was noted from PT to 1M in Global health 
status (p = .768). However, it increased significantly from 1M to 3M (p = .039). For functional scales, 
physical functioning (PF 2) and role functioning (RF 2) decreased significantly from PT to 1M (PF 2; p 
= .001, RF 2; p = .004), while RF2, EF, and SF increased significantly from 1M to 3M (RF 2; p = .005, 
EF; p = .048, SF; p = .007). Only RF2 indicated a significant change in both PT to 1M and 1M to 3M 
(Fig. 3a). In symptom scales, fatigue (FA), dyspnea (DY), senses problems (HNSE), speech problems 
(HNSP), trouble with social eating (HNSO), trouble with social contact (HNSC), opening mouth 
(HNOM), and weight gain (HNWG) decreased significantly from PT to 1M (FA; p = .004, DY; p = .011, 
HNSE; p = .021, HNSP; p < .001, HNSO; p = .027, HNSC; p = .001, HNOM; p = .009, HNWG; p 
= .010).  Furthermore, FA, pain (PA), insomnia (SL), appetite loss (AP), HNSW, , HNSP, HNSO, 
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HNSC, and HNOM increased significantly from 1M to 3M (FA; p = .011, PA; p = .022, SL; p = .037, AP; 
p = .027, HNSW; p = .010, HNSP; p = .001, HNSO; p = .043, HNSC; p < .001, HNOM; p = .002). In 
addition, FA, HNSP, HNSO, HNSC, and HNOM showed significant change in both PT to 1M and 1M to 
3M (Fig. 3b). 
Correlation between QOL items and other measurement items 
From PT to 1M, PF2 showed significant strong correlation with weight (r = .490, p = .001), 
BMI (r = .485, p = .001), TP (r = .581, p < .001), and FOIS (r = .419, p = .007). HNSP showed significant 
strong correlation with TP (r = -.424, p = .006). HNSC also showed significant strong correlation with 
weight (r = -.512, p = .001), BMI (r = -.537, p < .001), SMM (r = -.415, p = .008), TP (r = -.615, p 
< .001), and FOIS (r = -.681, p < .001) (Table 2). From 1M to 3M, RF2 demonstrated significant 
correlation with weight (r = -0.497, p = .001) and BMI (r = -.447, p = .004). Further, EF, SF, SL, and AP 
demonstrated significant correlation with FOIS (EF: r = .552, p < .001; SF: r = .517, p = .001; SL: r = 
-.549, p = .001; and AP: r = -.427, p = .007) (Table 3).  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
15 
 
Discussion 
In this study, we investigated the relationship between the side effects of HNC surgical 
treatment and QOL. The results showed that several aspects of muscle mass related measurements and 
oral function measurements, particularly feeding function, were significantly deteriorated following HNC 
surgical treatment with incomplete recovery at 3 months post-treatment. Regarding QOL measurement, 
only RF2 indicated significant decrease following HNC surgical treatment in functional scales. However, 
several factors in symptom scales indicated significant decrease following treatment. All muscle mass- 
related measurements and oral function measurements, including feeding function, indicated significant 
relationship with QOL. Furthermore, different patterns of relationships were obtained at the 1M vs. 3M 
time points. 
The reduction of oral function might be related to the surgical region of HNC. In this study, 
patients underwent only surgical treatment, and although oral function decreased after surgical treatment, 
it was recovered after 3 months. Unlike external beam radiation therapy and CRT, surgical treatment has 
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less additional chronic effects on oral function [24]. However, surgical treatment has strong acute side 
effects such as wound pain, and this might have influenced the result of this study. Moreover, the patients 
in this study underwent oral function rehabilitation, such as tongue strength, LC, and respiratory muscle 
strength training. These rehabilitations helped to improve oral function. In addition, majority of patients 
in this study (58%) had stage I or II. These patients treated with free tissue transfer. It was reported that 
single-stage reconstruction of head and neck like free tissue transfer reconstruction defected with much 
greater success and less morbidity [25]. 
The QOL of HNC patients has been reported to decrease after treatment and did not recover to 
baseline level [26]. In this study, the same tendency was noted in the symptom scale evaluation items. At 
1M, the FA, DY, HNSE, HNSP, HNSO, HNSC, HNOM, and HNWG were significantly decrease from 
that at PT. One possible reason might be that patients were still not fully recovered at this time point 
because of anatomical changes in the pharynx and oral cavity, decrease of dexterity, limitations in range 
of movement, and decrease in moving speed.  
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From PT to 1M, significant relationships were noted between QOL assessments and other 
measurements (14 items of muscle mass related measurements, 10 items of oral function measurements, 
and 5 items of feeding function). These results indicate that both muscle mass related measurements and 
oral function measurements had significant effects on QOL, and these functions were not recovered from 
at 1 month after surgical treatment. In this study, because of pain and/or healing process of wound area, 
over a week was necessarily to begin rehabilitation after surgical treatment for patients who underwent 
minor surgical treatment like partial glossectomy. Moreover, it is thought that a longer time was necessary 
to begin rehabilitation after surgical treatment for patients who underwent major surgery such as 
reconstructive surgery of the oral cavity. The common oral morbidities during the early stage of HNC 
treatment include dysphagia, oral pain, and oral dryness [24]. This might have caused the significant 
association between oral function and QOL. Moreover, some patients were still hospitalized at 1 month 
postoperative, and others were placed on tube feeding, causing difficulty in achieving adequate nutrition. 
In addition, some patients needed modified diets, which might have caused the significant association of 
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BMI and weight with QOL.  
Meanwhile, from 1M to 3M, different relationships were noted between QOL assessments and 
other measurements (5 items of muscle mass-related measurements, one item of oral function 
measurements, and 8 items of feeding function). Particularly, the evaluation measurements of oral 
function decreased to only a measurement (LC) between 1M and 3M. This indicated that a decrease in 
oral function had significant effect on QOL at the early stage following treatment. However, the effect 
became weak at 3 months postoperative. One possible reason might be that rehabilitation of oral function 
improves oral function (TP, LC). Nevertheless, feeding function (FOIS), which involves complex 
movement (both oral and pharyngeal), remained significantly correlated with QOL, indicating that oral 
function requiring complex movements such as feeding, speech, and social contact had stronger effect on 
QOL than simple function such as TP and LC. It was reported that social oral function, such as speech 
and eating, had strong effects on QOL during the late stage after treatment [27]. Similar results were 
obtained in this study. 
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The difference in correlation between PT - 1M and 1M - 3M is considered to be primarily due 
to functional deterioration because of surgical treatment and changes in the social environment. A 
previous study suggested that factors influencing QOL assessment were highly correlated with the time 
period after surgery and social environment of patients after social reversion [28]. In this study, single 
function such as LC and TP showed a significant correlation with change in QOL item at 1M. However, 
only LC indicated significant correlation to QOL assessment. Meanwhile, measurement items involving 
many factors (FOIS, SMM, and SLM) were correlated with QOL. Other QOL items correlated with other 
measurements did not change at PT - 1M and 1M - 3M. As for correlation coefficients, no factors 
showing strong correlation were recognized. This point might indicate that the QOL of HNC patients who 
underwent surgical treatment is influenced by multiple factors, and not a single factor. This means that 
improving the QOL of HNC patients requires a multifactorial approach, and strategies need to be 
patterned according to the time posttreatment. Dysphagia is among the most prevalent and debilitating 
symptoms resulting from HNC treatment. It has been reported that different mechanisms may contribute 
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to the development and maintenance of dysphagia during HNC treatment [8]. The pattern in correlation 
between QOL and functional assessment items differed according to the time point after treatment. 
Limitations  
This prospective cohort study included a small sample owing to its single-center design and 
loss to follow-up. Patient drop out during a prospective HNC study is not unusual [29,30]. In addition, 
patients were only followed for 3 months posttreatment. Postoperative dysfunction persists over 1 month 
and over 3-12 months after major surgery and radiation therapy, respectively [31,32]. Furthermore, 
additional variables such as type, amount, and duration of medications (particularly pain medications) 
might have influenced the results. Thus, to better clarify the proposed patterns reported in the current 
study, future studies should incorporate larger samples, follow patients for a longer post-treatment 
duration, and consider additional variables that potentially influence the observed outcomes. In this study, 
we did not evaluate physical function such as walking speed, hand grip, and performance of activities of 
daily living. The correlation between the QOL of HNC patients who underwent surgical treatment and 
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physical function should be investigated in future studies. In addition, it will be necessary that we 
consider classification by primary site (e.g., tongue, faucial arch, and pharynx) and identify the difference 
in treatment methods (surgery, radiation therapy, chemo therapy, and combined therapy). 
Conclusion 
Muscle mass-related measurements, oral function measurements, and feeding function deteriorate 
significantly following surgical treatment for HNC and are not recovered completely at 3 months 
posttreatment. Furthermore, the different patterns of relationships between QOL measurements and oral 
functions or muscle mass-related measurements obtained at each assessment point indicate that different 
factors influence the QOL in HNC patients who undergo surgical treatment.  
Compliance with Ethics Standards 
 The authors declare that they have no conflicts of interest. 
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 Research involving Human Participants and/or Animals: This study was approved by the Ethics 
Committee of Showa University School of Medicine (Approval no. 2355). 
 Informed consent: Informed consent was obtained from all individual participants included in 
the study  
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Figure Legends  
Fig. 1 Muscle mass related measurement outcomes 
a: Change in weight; b: Change in BMI; c: Change in SLM; d: Change in SMM 
Fig. 2 Oral function measurements and feeding outcomes 
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a: Change in LC; b: Change in TP; c: Change in FOIS  
Fig. 3 QOL measurement outcomes 
a: Significant change in functional scale; b: Significant change in symptom scales  
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